Comparative <i>in vitro</i> α-amylase Inhibitory Activity of <i>Carica papaya</i> Leaf Extract and Biosynthesised Gold Nanoparticles
The postprandial hyperglycemia that occurs in diabetes mellitus could be prevented or managed by the inhibition of the activity of pancreatic α-amylase. This study was carried out to comparatively check the inhibition potential of Carica papaya leaf extract and its biosynthesised gold nanoparticles (AuNPs). In this study, Carica papaya leaves were collected, and an extract was prepared; then, phytochemical screening of Carica papaya leaves was carried out. Further, this extract was used for the synthesis of AuNPs. Synthesised nanoparticles were characterised by FTIR, SEM, EDAX, and DLS for the analysis of surface functional groups, the size, elemental composition, zeta potential, and zeta size, respectively. Further standard methods for enzyme inhibition assay were approached to evaluate the anti-α- amylase activity of Carica papaya leaves and AuNPs. Carica papaya leaf (10-50mg/mL) and AuNPs (0.0625-1mg/mL) showed inhibition against the pancreatic α-amylase. The highest inhibition at 50mg/mL concentration of leaf extract exhibited 73% inhibition, and AuNPs exhibited 37.8% at 1mg/mL. The characterisation of AuNPs confirmed the functional groups, particle size, and elemental composition. These findings indicate that the crude leaf extract exhibited greater inhibition against pancreatic α- amylase than the biosynthesised gold nanoparticles. However, the study is limited to enzyme-based assays, and further biological validation is required to establish physiological relevance. Major Findings: The leaf extract exhibited higher inhibition compared to AuNPs. Although AuNPs showed activity at lower concentrations, they did not achieve 50% inhibition within the tested range. These findings indicate that the crude extract demonstrated greater inhibitory effectiveness under in vitro conditions.